{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T03:07:11Z","timestamp":1768014431222,"version":"3.49.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.placenta.2024.12.012","type":"journal-article","created":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T00:02:36Z","timestamp":1734652956000},"page":"140-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Profilin-1 levels in preeclampsia: Associations with disease and adverse neonatal outcomes"],"prefix":"10.1016","volume":"159","author":[{"given":"Sadullah","family":"\u00d6zkan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7623-3589","authenticated-orcid":false,"given":"Alperen","family":"Aksan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahri B.","family":"F\u0131ratl\u0131gil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dilara","family":"Kurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serap","family":"Sucu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asl\u0131han","family":"Co\u015fkun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kadriye Yakut","family":"Y\u00fccel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. Turhan","family":"\u00c7a\u011flar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaprak Engin","family":"\u00dcst\u00fcn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.placenta.2024.12.012_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20042994","article-title":"Preeclampsia: recent advances in predicting, preventing, and managing the maternal and fetal life-threatening condition","volume":"20","author":"Chang","year":"2023","journal-title":"Int. J. Environ. Res. Publ. Health"},{"issue":"1","key":"10.1016\/j.placenta.2024.12.012_bib2","article-title":"Immunologic aspects of preeclampsia","volume":"4","author":"Boulanger","year":"2024","journal-title":"AJOG Glob Rep"},{"issue":"3","key":"10.1016\/j.placenta.2024.12.012_bib3","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/HYPERTENSIONAHA.120.15552","article-title":"Usefulness of the sFlt-1\/PlGF (soluble fms-like tyrosine kinase-1\/placental growth factor) ratio in diagnosis or misdiagnosis in women with clinical diagnosis of preeclampsia","volume":"76","author":"Lea\u00f1os-Miranda","year":"2020","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.placenta.2024.12.012_bib4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1161\/HYPERTENSIONAHA.120.15146","article-title":"Prediction of preeclampsia-related adverse outcomes with the sFlt-1 (soluble fms-like tyrosine kinase 1)\/PlGF (placental growth factor)-ratio in the clinical routine: a real-world study","volume":"77","author":"Dr\u00f6ge","year":"2021","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.placenta.2024.12.012_bib5","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000477903","article-title":"Update on the diagnosis and prognosis of preeclampsia with the aid of the sFlt-1\/PlGF ratio in Singleton pregnancies","volume":"43","author":"Herraiz","year":"2018","journal-title":"Fetal Diagn. Ther."},{"key":"10.1016\/j.placenta.2024.12.012_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.preghy.2021.12.003","article-title":"Clinical interpretation and implementation of the sFlt-1\/PlGF ratio in the prediction, diagnosis and management of preeclampsia","volume":"27","author":"Verlohren","year":"2022","journal-title":"Pregnancy Hypertens"},{"issue":"2","key":"10.1016\/j.placenta.2024.12.012_bib7","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/uog.26032","article-title":"Clinical utility of sFlt-1 and PlGF in screening, prediction, diagnosis and monitoring of pre-eclampsia and fetal growth restriction","volume":"61","author":"Stepan","year":"2023","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"15","key":"10.1016\/j.placenta.2024.12.012_bib8","first-page":"8112","article-title":"Evaluation of profilin 1 as a biomarker in myocardial infarction","volume":"24","author":"Paszek","year":"2020","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"2","key":"10.1016\/j.placenta.2024.12.012_bib9","doi-asserted-by":"crossref","first-page":"71","DOI":"10.5830\/CVJA-2016-009","article-title":"Pre-eclampsia: its pathogenesis and pathophysiolgy","volume":"27","author":"Gathiram","year":"2016","journal-title":"Cardiovasc J Afr"},{"issue":"1","key":"10.1016\/j.placenta.2024.12.012_bib10","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1414838","article-title":"Predictive value of the sFlt-1:PlGF ratio in women with suspected preeclampsia","volume":"374","author":"Zeisler","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.placenta.2024.12.012_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/10641955.2013.784788","article-title":"Clinical characterization and outcomes of preeclampsia with normal angiogenic profile","volume":"32","author":"Rana","year":"2013","journal-title":"Hypertens. Pregnancy"},{"issue":"6","key":"10.1016\/j.placenta.2024.12.012_bib12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/uog.15997","article-title":"sFlt-1\/PlGF ratio test for pre-eclampsia: an economic assessment for the UK","volume":"48","author":"Vatish","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"issue":"2s","key":"10.1016\/j.placenta.2024.12.012_bib13","doi-asserted-by":"crossref","first-page":"S1071","DOI":"10.1016\/j.ajog.2020.07.020","article-title":"First trimester preeclampsia screening and prediction","volume":"226","author":"Chaemsaithong","year":"2022","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2024.12.012_bib14","series-title":"Comparison of FMF and NICE Algorithms in Early Preeclampsia Screening at 11-13 Weeks Gestation","author":"Voelker","year":"2019"},{"issue":"1","key":"10.1016\/j.placenta.2024.12.012_bib15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/AOG.0000000000004149","article-title":"Biomarkers and the prediction of adverse outcomes in preeclampsia: a systematic review and meta-analysis","volume":"137","author":"Lim","year":"2021","journal-title":"Obstet. Gynecol."},{"issue":"4","key":"10.1016\/j.placenta.2024.12.012_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0230955","article-title":"Systematic review of prediction models for gestational hypertension and preeclampsia","volume":"15","author":"Antwi","year":"2020","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.placenta.2024.12.012_bib17","first-page":"10","article-title":"Placental vimentin expression in preeclampsia and gestational diabetes mellitus","volume":"30","author":"Asir","year":"2024","journal-title":"Gynecology Obstetrics & Reproductive Medicine"},{"issue":"2","key":"10.1016\/j.placenta.2024.12.012_bib18","first-page":"122","article-title":"Early serum heme oxygenase-1, soluble vascular endothelial growth factor receptor-1, and B-cell lymphoma\/leukemia-2 levels and unfavorable obstetric outcomes","volume":"28","author":"Sutcu","year":"2022","journal-title":"Gynecology Obstetrics & Reproductive Medicine"}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400424008038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400424008038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T17:18:04Z","timestamp":1736615884000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400424008038"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":18,"alternative-id":["S0143400424008038"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2024.12.012","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Profilin-1 levels in preeclampsia: Associations with disease and adverse neonatal outcomes","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2024.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}